Theme · live manifest · live theme JSON
MedTech Long '24: Lab Research & Trials
7 tickers · $52.49B total market cap
Group: MedTech Long
This basket targets contract research, diagnostics, and lab services companies poised to benefit from a cyclical rebound in biotech funding, a Trump-led push for domestic reshoring, and a renewed policy and AI-enabled focus on accelerating trials. These firms are critical infrastructure for biopharma innovation, increasingly insulated from China exposure and positioned for long-term demand growth from oncology, rare disease, and gene therapy trials.
MedTech Long '24: Lab Research & Trials tracks 7 publicly listed stocks in this theme: CDMO, CRL, DGX, FTRE, LH, MRVI, NOTV. See the constituent table for details.
Thesis update: 2025-04-14
Constituents
Build 20260520T081747
| Company | Previous Quarter Report Date | Next Expected Report Date | Last Quarter Earnings Move % | Earnings Move % | Intra-Quarter Move % | Since Last Report % | Market cap | Weight |
|---|---|---|---|---|---|---|---|---|
Quest Diagnostics IncorporatedDGX | 04/21/2026 (BMO) | 04/21/2026 (BMO) | 9.45% | 3.92% | -6.22% | -6.67% | $21.08B | 14.2857 |
Labcorp Holdings Inc.LH | 04/30/2026 (BMO) | 04/30/2026 (BMO) | -1.37% | -0.51% | -7.76% | -0.84% | $20.80B | 14.2857 |
Charles River Laboratories International, Inc.CRL | 05/07/2026 (BMO) | 05/07/2026 (BMO) | 3.60% | -2.26% | 10.65% | -14.18% | $7.34B | 14.2857 |
Fortrea Holdings Inc.FTRE | 05/05/2026 (BMO) | 05/05/2026 (BMO) | 3.68% | 27.67% | 14.27% | -12.34% | $1.30B | 14.2857 |
Maravai LifeSciences Holdings, Inc.MRVI | 05/07/2026 (AMC) | 05/07/2026 (AMC) | 9.20% | 23.10% | 10.67% | -12.99% | $1.17B | 14.2857 |
Avid Bioservices, Inc.CDMO | 12/10/2024 (BMO) | — | -0.33% | — | 2.13% | — | $798.9M | 14.2857 |
Inotiv, Inc.NOTV | 05/11/2026 (AMC) | 05/11/2026 (AMC) | -13.09% | -18.81% | -6.50% | 5.71% | $9.0M | 14.2857 |
| Average | 1.59% | 5.52% | 2.46% | -6.89% | $7.50B | 14.2857 | ||
| Median | 3.60% | 1.71% | 2.13% | -9.51% | $1.30B | 14.2857 | ||
| Std Dev | 7.13% | 15.76% | 8.73% | 7.25% | $8.79B | 0.0% | ||
| Min | -13.09% | -18.81% | -7.76% | -14.18% | $9.0M | 14.2857 | ||
| Max | 9.45% | 27.67% | 14.27% | 5.71% | $21.08B | 14.2857 | ||
| % Positive Tickers | 57.14% | 50.00% | 57.14% | 16.67% |
* Provisional value: before LstRpt% reaches its 2-day post-report lock window (BMO/AMC adjusted), EarningsPerf is calculated from current vs pre-report and then locks to final LstRpt%.